FTC sues key pharmacy profit professionals around insulin charges The company brought motion towards Caremark, Specific Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating methods “artificially inflated” the listing cost of life-preserving insulin prescription drugs. Insurers will continue on vertically integrating to help keep more earnings in-dwelling, and https://daves-hot-chicken-nutriti75318.vidublog.com/29918323/healthcare-news-an-overview